lead position
Trademarks
Features list
-
David Schwartz, with contributions from Walter Chan, analyses recent developments in Canadian IP law, including the impact of the implementation of international treaties and free-trade agreements and the country’s IP Strategy
-
Wu Xiaoping and Hu Honghui of Wanhuida examine the methodology employed by the Patent Reexamination Board to determine non-obviousness of an improvement invention
-
Robert Reading of CompuMark examines some of the common perceptions of pharmaceutical trademarks and how they measure up in reality
-
Masato Iida of Shiga examines examples of patent claims related to antibody drugs, assessing which data is included in claims
-
Erick Robinson of Dunlap, Bennett & Ludwig examines three underused patent strategies for companies, including those in the US, to succeed in China
-
Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption
Local Insights